US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms
AI KEY TAKEAWAYS (TL;DR)
- A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval
- Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […] The post US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms appeared first on Good News Network
Why it matters: Highlights progress and positive advancements shaping a better world.
A Japanese pharma company has developed a drug that treats the root cause of a leading form of narcolepsy, and is celebrating as it becomes the first of its kind to receive American FDA approval. Narcolepsy type-1 afflicts 120,000 people in the US, and is characterized by sudden bouts of intense daytime drowsiness, disrupted nighttime […] The post US Approves First Drug That Targets Root Cause of Narcolepsy Rather Than its Symptoms appeared first on Good News Network.
More Uplifting POSITIVE Stories
Chinese Commercial Reactor Achieves Nuclear Fusion with Clean Hydrogen-Boron Fuel
Genetic Analysis All But Confirms the Most Unique of Humpback Populations Is Actually a Subspecies
Stunning Collection of Stolen Greek Artifacts Spanning 5,000 Years Were Just Returned to Greece